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Virulence characteristics of hcp+ 
Campylobacter jejuni and Campylobacter coli 
isolates from retail chicken
Nicolae Corcionivoschi1,2*, Ozan Gundogdu3, Lynn Moran1, Carmel Kelly1, Pam Scates1, Lavinia Stef2, 
Ada Cean2, Brendan Wren3, Nick Dorrell3 and Robert H Madden1*
Abstract 
Background: Recently the Type VI secretion system (T6SS), which can play a significant role in bacterial survival and 
pathogenesis, was reported in Campylobacter spp., having the hcp gene as a key component.
Methods: Campylobacteriosis is associated with the consumption of infected chicken meat. Our study aimed to 
explore the presence of T6SS in C. jejuni (n = 59) and C. coli (n = 57) isolates, from retail raw chicken and to investigate 
their pathogenic potential. The hcp gene was used as an indicator for the T6SS presence.
Results: Using multiplex PCR we have identified a significantly higher prevalence of hcp in C. coli isolates (56.1%) 
than in C. jejuni (28.8%) and AFLP analysis of the isolates showed a high degree of genetic similarity between the 
isolates carrying the hcp gene. Genome sequencing data showed that 84.3% of the C. coli and 93.7% of the C. jejuni 
isolates had all 13 T6SS open reading frames. Moreover, the virulence characteristics of hcp + isolates, including 
motility and the ability to invade human intestinal epithelial cells in vitro, were significantly greater than in the control 
strain C. jejuni 12502; a human isolate which is hcp positive.
Conclusion: Overall, it was discovered that hcp+ C. coli and C. jejuni isolated from retail chicken isolates posses 
genetic and phenotypic properties associated with enhanced virulence. However, since human infections with C. 
coli are significantly less frequent than those of C. jejuni, the relationship between virulence factors and pathogenesis 
requires further study.
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Background
Campylobacter species are the most common foodborne 
pathogens in humans but also commensals in many farm 
animals, including cattle, swine and poultry. Campylo-
bacters are Gram-negative, microaerophilic microorgan-
isms possessing a corkscrew motility phenotype which 
has proven significance in achieving penetration of the 
human gut epithelium in order to establish infection in 
humans, and colonisation in poultry [1, 2].
The most frequent cause of campylobacteriosis in the 
UK is poultry meat [3] and up to 90% of poultry carcasses 
are contaminated with C. jejuni [4, 5] and C. coli [6]. The 
virulence properties of campylobacters are, however, yet 
to be fully defined and will be dependent on the genetic 
content of each individual isolate. Campylobacters can 
cause a range of illnesses; diarrhoea, reactive arthritis 
and in some cases infection can subsequently lead to 
serious neuromuscular disorders such as Guillain-Barré 
syndrome [7, 8]. One pathogenic property employed by 
bacteria and reported in Campylobacter spp., is the use 
of secretion systems to export toxins (proteins) into their 
environment, or directly through membranes into neigh-
bouring eukaryotic [9] or prokaryotic [10] cells.
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The Type VI secretion system (T6SS), has been 
reported in Campylobacter [11], as well as other Gram 
negative bacteria [12]. In C. jejuni this secretion system 
is potentially associated with more severe forms of dis-
ease as it can confer cytotoxicity toward red blood cells 
[11]. A significant component of the T6SS is the product 
of the hcp gene and the presence of this gene has been 
described as being indicative of a functional T6SS in C. 
jejuni [13]. Further, it has been reported as being more 
prevalent in strains isolated from patients experiencing 
bloody diarrhoea, than those having non-bloody diar-
rhoea [13]. Also, hcp+ strains of C. jejuni have shown 
increased abilities to adhere to, and invade, the host gas-
trointestinal epithelium in vivo [14].
This study has focused only on the hcp+ isolates as 
information on their virulence is lacking for this emerg-
ing virulence mechanism. This study aimed to analyze the 
C. jejuni and C. coli isolates obtained from retail packs of 
raw chicken produced in Northern Ireland for the pres-
ence of the T6SS and to test their pathogenic potential.
Methods
Microbiology
All media were supplied by Thermo Fisher Scientific Ltd, 
Basingstoke UK, and all reagents supplied by Sigma-
Aldrich Ltd, Gillingham, UK unless otherwise stated. All 
incubations were performed microaerobically (85% N2, 
10% CO2 and 5% O2, all v/v) in a Don Whitley MACS 
500 workstation (Don Whitley Scientific, Shipley, UK) at 
41.5°C unless otherwise stated.
Campylobacter isolation and identification
Samples of retail chicken were prepared as previously 
described [15]. Briefly, we have used a stomacher bag 
and buffer peptone water (225  ml) to emulsify 25  g of 
skin and flesh sample in a Seward 400 blender (Seward 
Ltd, Worthing, UK). The emulsified sample (25 ml) was 
transferred into a container with 225 ml of BBW (Bolton 
broth). The BS EN ISO10272-1:2006 [16] was followed 
as previously described [17]. The 225  ml BB were first 
incubated for 4  h at 37°C, followed by a second incu-
bation step of 24  h at 41.5°C. The resulting culture was 
plated on modified charcoal cefoperazone deoxycholate 
agar (mCCDA) and incubated at 41.5°C until single colo-
nies were countable. In order to confirm that the result-
ing colonies represent a typical Campylobacter colony 
the motility and oxidase tests were performed. DNA 
was extracted from each individual isolate using half of 
a 10 μl loopful in 1 ml of SET buffer (150 mmol l−1 NaCl, 
15  mmol  l−1 EDTA, 10  mmol  l−1 Tris–HCl, pH 8.0). 
Long-term stocks (−80°C) were prepared in 1 ml of NB 
plus (nutrient broth plus) containing 10% (v/v) glycerol 
Overall 59 C. jejuni and 57 C. coli poultry isolates from 
Northern Ireland producers were selected from the cul-
ture collection yielded by the survey [15] and investigated 
in this study.
Genome sequencing, assembly and annotation
We have performed genome sequencing of all our 52 [18] 
C. jejuni and C. coli isolates as described previously by 
Ugarte Ruiz et al. [19] using Illumina MiSeq 2 × 150 bp 
paired-end sequencing. To analyze the data quality 
FastQC was used [20]. In order to evaluate the sequenc-
ing reads the Trimmomatic was used at the follow-
ing parameters: (v0.32) ‘leading’ and ‘trailing’ setting 
of 3, a ‘slidingwindow’ setting of 4:20 and a ‘minlength’ 
of 36 nucleotides) [21]. BWA-MEM (v0.7.7-r441) was 
used to map the reads using the genome sequence of 
C. jejuni NCTC 11168 (AL111168) as Ref. [22]. Vel-
vet Optimiser (v2.2.5) using n50 optimization [23, 24] 
was used to perform assembly. The reference strain C. 
jejuni NCTC 11168 (AL111168) was used to complete 
Contigs using ABACAS (v1.3.1) [25]. In order to final-
ize annotation of all the genomes we have used RATT 
[26] and the references species C. jejuni NCTC 11168 
(AL111168), C. jejuni 414 (CM000855), C. jejuni RM1221 
(CP000025), C. coli 76339 (HG326877), C. coli CVM 
N29710 (CP004066), C. concisus 13826 (CP000792), C. 
fetus 82-40 (CP000487), C. jejuni 81-176 (CP000538), C. 
jejuni M1 (CP001900) and C. lari RM2100 (CP000932). 
The Artemis and ACT software [27] were used to read 
the genomes. T6SS ORFs were identified using BLAST 
[28, 29].
Amplified fragment length polymorphism (AFLP)
The ABI 3100 Genetic Analyzer was used to perform 
automated amplified fragment length polymorphism 
(AFLP) as previously described [30, 31]. The resulting 
data was analysed using the BioNumerics V4.6.1 soft-
ware and the Pearson product-moment correlation coef-
ficient was required to normalize the profile similarities. 
Following normalization the unweighted pair group with 
mathematical average (UPGMA) method was used for 
clustering and dendrogram assembly. As controls DNA 
from standard C. jejuni and C. coli cultures were used 
in each run. In our experiments the similarities between 
standards were ≥90% having a position tolerance setting 
of 0.07%, and a profile size range of 50–500 bp.
PCR detection of hcp and gltA genes
To detect the hcp multiplex PCR analysis was used 
as previously described using the gltA as a control 
housekeeping gene [13]. For amplification of gltA the 
primers gltAF (gcccaaagcccatcaagcgga) and gltAR 
(gcgctttggggtcatgcaca) and for the amplification of the 
hcp gene primers hcpF (caagcggtgcatctactgaa) and hcpR 
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(taagctttgccctctctcca) were used. C. jejuni NCTC 12502 
served as the hcp+ control.
Motility assay
The motility of all hcp+ isolates (n = 51), plus one hcp− 
strain and NCTC 12502, was compared based on the 
method of Corcionivoschi et al. [32]. Briefly, 5 µl of cul-
ture [48  h, grown on blood agar and recovered in 1  ml 
brain heart infusion (BHI) broth] was inoculated into the 
centre of semi-solid BHI plates (0.4% agar). The radius of 
the disc of visible growth was measured after incubation 
(48 h). The experiment was carried out in triplicate.
Resistance to bile salts
The resistance of the isolates to bile salts was studied 
based on the method of Stef et al. [33]. Briefly, each iso-
late was grown confluently on blood agar (48  h) then 
2.5 ml BHI broth added and mixed. This cell suspension 
(1 ml) was used to inoculate BHI broth (10 ml), and BHI 
broth containing 4.0% (wt/vol) bile salts (10  ml), dis-
pensed into 30  ml bottles. The bottles were incubated 
(24  h) after which 20  μl was removed and added to 
100 μl of water. Serial dilutions were made in maximum 
recovery diluent, plated onto mCCDA, incubated (48 h), 
and enumerated. The experiment was carried out in trip-
licate. Due to complete lack of resistance of some of the 
isolates we have scored the resistance as (+) resistant, 
(±) intermediate and (−) sensitive.
Gentamicin protection assay
In order to quantify the invasive capability of C. jejuni and 
C. coli isolates the gentamicin protection assay has been 
used as previously described [34]. Intestinal epithelial 
cells (HCT-8) were grown for up to 18  h until a conflu-
ence of 1 ×  105 has been reached. The bacterial isolates 
were cultivated on blood agar plates for 2 days followed by 
serial dilution to reach an OD600 of 0.4. Once the HCT-8 
cells reached the desired confluence they were washed 
with 1  ml of PBS followed by the addition and 2  ml of 
fresh tissue culture media. In our current study an MOI 
(multiplicity of infection) of 10 was used. One centrifu-
gation step was necessary (250×g for 5 min) followed by 
incubation for 3 h at 37°C, in microaerophilic conditions 
(10% CO2). The infected cells, previously treated with 
400 μg/ml, were washed three times in 1 ml PBS followed 
by exposure to 0.1% Triton X-100 at 37°C during a 2  h 
period. The lysate was diluted and spread on Mueller–
Hinton agar plates and colonies counted after 2–3  days 
incubation or until colonies were visible on plates. The 
ratio between the total number of CFU and the initial 
inoculum was used to calculate the efficiency of invasion. 
The experiments were performed in triplicate.
Visualisation of capsular polysaccharide (CPS)
CPS was extracted from the isolates using the method of 
Hitchcock [35]. Briefly, plate grown bacteria were lysed 
for 5 min at 100°C in 31.25 mM Tris–HCl (pH 6.8), 4% 
sodium dodecyl sulphate, 0.025% bromophenol blue, and 
20% glycerol. Proteinase K (20 mg ml−1 proteinase) was 
added to the lysate and incubated for 1  h at 50°C. The 
lysate, containing the polysaccharides, were separated in 
10% Bis–Tris gels (NuPage Novex) for 1 h at 100 V (Invit-
rogen, Paisley, United Kingdom) and he gels were stained 
with Alcian blue [36].
Statistical analysis
Experiments were repeated three times in separate 
instances. Means of standard deviations (±) were used to 
represent the repeated experiments. Prism software was 
required for graph design and the unpaired Student t test 
to calculate the significance of data. The resulting P val-
ues were considered significant if their calculated values 
were <0.05.
Results
Prevalence of hcp and identification of T6SS open reading 
frames in C. coli and C. jejuni isolates
Using PCR, the presence of the hcp gene in the C. jejuni 
and C. coli isolates obtained packed retail chicken pro-
duced in Northern Ireland was determined, Figure 1. A 
higher prevalence was found in C. coli isolates (56.1%) 
than in C. jejuni (28.8%), Table  1. The gltA housekeep-
ing gene in the multiplex PCR served as a positive con-
trol, and confirmed the isolates were all Campylobacter 
spp. C. jejuni strain 108 (JX436460) was used as refer-
ence when analysing the genomes of the chicken isolates 
in order to identify the presence of the T6SS ORFs. The 
hcp+ isolates were next investigated for the T6SS ORFs 
integrity. The results showed that 84.3% of the C. coli and 
93.7% of the C. jejuni isolates, detected positive for hcp, 
possess all 13 T6SS ORFs, Table 2.
Relative motility of isolates
Motility represents and important virulence factor in 
campylobacters increasing their ability to invade and col-
onise the gut epithelium. We have next investigated the 
motility of the hcp positive C. jejuni and C. coli isolates in 
order to differentiate and select them for further patho-
genicity investigations, using motility as an exclusion 
factor. Our initial results show that none of the hcp+ C. 
jejuni and C. coli isolates displayed motility significantly 
less than that of the control strain C. jejuni 12502 (data 
not shown), p < 0.05 and five isolates from each species 
were selected for further study (Figure 2), based on their 
high levels of motility.
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AFLP analysis of a subset of C. jejuni and C. coli strains
AFLP was used to determine the genetic difference 
between the five strains of C. coli and of C. jejuni selected 
for further study. The C. coli isolates; RC037, RC038 and 
RC013, 026 produced two clusters with 95.8% genetic 
similarity and 97.8% respectively. The degree of genetic 
similarity between these two clusters and C. coli isolates 
RC430 and RC008 was over 80%. When the hcp+ isolates 
were compared with the negative control, RC018, the 
degree of similarity was also very high, >70%, (Figure 3a). 
The C. jejuni 12502 control has been included in the 
AFLP diagram to specifically emphasize the genetic dif-
ferences between C. jejuni and C. coli isolates and simi-
larly for C. coli RC018 for the C. jejuni clustering.
C. jejuni isolates showing higher motility were also 
investigated by AFLP (panel b). Isolate RC039 formed a 
separate cluster with the control strain C. jejuni 12502 at 
a degree of similarity of over 50% (cluster A) and isolates 
RC317, RC526, RC188 and RC185 clustered together at 
a similarity >80% (cluster B). When cluster A was com-
pared to cluster B the degree of similarity was approxi-
mately 50%. Isolate RC179 showed a low degree of 
similarity, approximately 35%, when compared to cluster 
A and B.
In vitro cell invasion abilities of hcp+ isolates
The ability of hcp+ C. coli and C. jejuni isolates to invade 
HCT-8 cells was studied using C. jejuni 12502 as a ref-
erence strain (Figure  4). Using gentamicin, higher inva-
siveness rates were determined for C. coli isolates RC037 
and RC130 when compared to C. jejuni invasiveness 
(p  <  0.05). For Approximately 4% of the inoculums was 
internalised with C. coli isolates RC008, RC013 and 
RC026, and C. jejuni isolates RC317, RC188, RC185 and 
RC179: significantly more the level of less than 2% seen 
for the control strain (p < 0.01). C. jejuni isolate RC039 
was most invasive, with approximately 6% of the inocu-
lum being internalised (p < 0.001). A positive correlation 
between motility and invasiveness was seen for of all the 
hcp+ C. coli and C. jejuni isolates. The hcp+ negative iso-
late (RC018) displayed invasiveness of less than 0.01% of 
the inoculum (data not shown).
Capsule polysaccharide profiles of C. coli isolates
Five isolates were chosen for study based on the high lev-
els recorded in the motility determinations noted above. 
C. coli isolates RC037 and RC038 showed low amounts 
of CPS with most of the polysaccharides having very 
high molecular weights, similar to the control strain C. 
jejuni 12502. Isolates RC008, RC013 and RC026 had CPS 
molecular weights similar to the negative control, isolate 
RC018. The C. jejuni positive isolates had very different 
CPS profiles, with only the isolates RC526 and RC018 
having profiles similar to each other, but dissimilar to C. 
jejuni 12502. Lower amounts of LOS were also detected, 
following staining with Alcian blue, for isolates RC039, 
RC526 and RC179, Figure 5. Due to the diversity of the 
capsule profiles obtained, between the different isolates, 
a capsule deficient mutant has not been used for com-
parison. We will focus in the future on the most virulent 
isolate and a mutant will be created for control purposes.
Bile salts resistance
The ability of hcp+ chicken isolates to survive in the pres-
ence of bile salts (Table  3). Most of the C. coli isolates 
showed no resistance to bile salts (RC037, RC430, RC013 
and RC026) with only isolate RC008 displaying interme-
diate resistance (i.e. lower counts compared to the con-
trol strain C. jejuni 12502). A similar pattern was also 
found with C. jejuni, with isolates RC039, RC317, RC188 
and RC185 showing no resistance to bile salts in vitro.
Figure 1 PCR detection of hcp in C. jejuni (n = 17) and C. coli (n = 32) isolates. Only positive isolates are shown, and one negative isolate (RC018). 
The positive control for hcp was C. jejuni 12502 and gltA served as the negative control for PCR reaction. Photoshop software was used to achieve 
the desired resolution.
Table 1 Prevalence of hcp gene in Campylobacter spp. iso-
lated from raw, retail chicken
Species Total number of iso-
lates
Number of hcp positive 
strains (%)
Campylobacter coli 57 32 (56.1)
Campylobacter jejuni 59 17 (28.8)
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Discussion
Campylobacters are the main cause of in human food 
poisoning in Europe and North America, with chicken 
meat identified as a major source of campylobacters, 
which grow profusely in the gut and crop of broiler chick-
ens. The European Food Safety Authority (EFSA) stated 
that reducing the numbers of Campylobacter in the intes-
tines at slaughter 1,000-fold would reduce the public 
health risk by at least 90%. Previous studies have shown 
that the virulence abilities, of Campylobacter chicken iso-
lates, are increased compared to human isolates [13, 37]. 
The Type VI secretion system novel protein translocation 
system has been described as a potentially new virulence 
factor active in vitro [11] and in vivo [14]. However, the 
role of T6SS in acute human disease remains to be deter-
mined, as the biological mechanisms involved are not 
yet fully understood. This study investigated the preva-
lence of T6SS in C. coli and C. jejuni chicken isolates and 
to characterise the virulence potential of these isolates 
in vitro.
The hcp gene is currently used as the main indicator 
for the presence of T6SS C. jejuni [11]. The incidence 
of hcp has been reported as being relatively higher in 
C. jejuni isolates from chickens in Asia, whilst and only 
a small proportion of chicken isolates in the UK were 
identified as positive for T6SS [13]. Given the patho-
genic potential of hcp+ positive campylobacters, this 
study investigated, by multiplex PCR, the presence of the 
hcp gene in both C. coli and C. jejuni isolates obtained 
Figure 2 Relative motility assay of hcp+ C. jejuni and C. coli isolates. 
The motility of five hcp positive C. jejuni and C. coli isolates was com-
pared to hcp+ control strain, C. jejuni 12502 in 0.4% BHI agar. Results 
are the mean of three separate experiments. The statistical signifi-
cance was determined using the Student t test.
Figure 3 AFLP analysis of C. coli and C. jejuni hcp positive chicken isolates. a shows the AFLP fingerprints of the five most motile C. coli isolates and 
b the C. jejuni isolates. The percentage of amino acid identity between banding patterns is indicated. For comparison we have used the hcp positive 
C. jejuni 12502 and the negative isolate RC018.
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from retail chicken produced in Northern Ireland. It has 
been reported that the prevalence of C. coli isolates in 
retail chicken is much lower than that of C. jejuni [18] 
but this study found that the incidence of hcp was higher 
in C. coli, than in C. jejuni, hence these strains could 
potentially display increased virulence abilities. How-
ever, epidemiological studies have found that only 7% of 
reported cases of campylobacteriosis are caused by C. 
coli and 93% by C. jejuni, with most of the C. coli cases 
being recorded in older patients [38]. No epidemiologi-
cal connection to the presence of hcp has been reported 
in C. coli. Our results show that the majority of the C. 
coli and C. jejuni isolates contained the complete set of 
ORFs required for a fully active T6SS. The characteri-
zation of the T6SS ORF was undertaken as it has been 
suggested [13] that the detection of the hcp gene alone 
might not actually indicate the presence of a full T6SS 
locus. This was demonstrated in Spanish isolates where 
it was shown that only 14% of the strains (n = 9) had a 
complete T6SS ORF [19].
In this study, analysis of the genetic similarities 
between isolates revealed similar results to those previ-
ously reported, i.e. suggesting that C. coli isolates were 
less diverse, based on the AFLP profiles, that C. jejuni 
isolates [39], probably due to C. coli showing more host 
specificity than C. jejuni [40].
Campylobacter species have emerged as gastrointesti-
nal pathogens in humans and commensals in birds [41] 
with motility as a phenotypic feature required to achieve 
both colonization [42] and internalization in surface 
intestinal epithelial layer [43]. The results reported above 
show that all of the hcp+ chicken isolates had greater 
motility than an hcp+ human isolate (C. jejuni 12502), but 
no direct link between the presence of the hcp gene and 
motility in Campylobacter has yet been reported. How-
ever, the observations reported above are supported by 
studies with other Gram-negative bacteria such as Aero-
monas hydrophila. A. hydrophila produces a cytotoxic 
enterotoxin, and associated with this toxin is a type II 
secretion system. However, it has also been reported that 
A. hydrophila possess a T6SS and that hcp increases not 
only motility but also protease and biofilm formation, 
thus significantly influencing the pathogenicity and sur-
vival of this microorganism [44].
In Campylobacter, motility is recognised as an impor-
tant virulence factor [1] and the chicken isolates in this 
study were shown, not only to be highly motile, but also 
very invasive when in vitro gentamicin protection assays 
were performed with human intestinal cells [33]. In 
Figure 4 Invasive ability of C. coli and C. jejuni isolates. Invasion 
of HCT-8 cells of C. coli (RC037, 430, 008, 013 and 026) and C. jejuni 
(RC039, 317, 188, 185 and 179) isolates. Statistical significance 
(Student t test) relative to the level of C. jejuni 12502 is indicated. The 
experiments were done in triplicate and on three separate occasions. 
The error bars represent standard deviations.
Figure 5 Capsule polysaccharides profiles of hcp positive isolates. 
Capsular polysaccharides were separated in 10% SDS-PAGE gels and 
stained with Alcian blue. The profiles of C. jejuni 12502 and C. coli 
RC018 served as controls for lipo-oligosaccharide (LOS).
Table 3 Resistance to bile salts
(+) resistance, (±) intermediate, (−) sensitive.
Isolate Control Campylobacter coli Campylobacter jejuni
12502 RC037 RC430 RC008 RC013 RC026 RC039 RC317 RC188 RC185 RC179
Bile salt resistance + – – ± – – – – – – ±
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general hcp− strains were poorly invasive, e.g. C. jejuni 
11168, with less than 0.1% of the inoculum invading the 
epithelial cells [34] but with hcp+ strains over 1% invades 
[14]. All of the hcp+ chicken isolates investigated in this 
study demonstrated greater invasiveness in the gen-
tamicin protection assay [14], when compared to the 
control. The involvement of hcp in C. coli in vitro viru-
lence is still under debate since our genomic sequencing 
results show that even the isolates with an incomplete 
ORF are not significantly different in virulence com-
pared to strains with complete ORFs. This suggests that 
in these isolates other virulence factors might also be 
involved.
To act as a haemolysin, hcp requires to be synthesised 
and subsequently injected into the host cell, using the 
fully functional T6SS. This process will require modifica-
tions of the bacterial surface structures, especially its pol-
ysaccharide capsule, to allow the T6SS to act effectively. 
The decrease in capsule production has been reported as 
necessary for effective T6SS mediated toxicity and viru-
lence [11]. Accordingly, the capsule polysaccharides of 
hcp+ isolates were studied to detect any differences in the 
molecular weights, or amounts, between these isolates. 
With isolate RC039, less CPS appeared to coincide with 
greater virulence characteristics, however this was not 
the case with the other isolates. However, in Campylo-
bacter de-capsulation can occur in the presence of epi-
thelial cells [34], hence the CPS profiles may not reflect 
their state during pathogenesis.
In order to successfully colonise humans, Campylo-
bacter will have to be resistant to the potentially lethal 
conditions present in the intestinal tract, and possess 
resistance to bile salts [45]. It has been suggested that 
deoxycholic acid, at physiological levels found in the 
human gut, can inhibit cell growth in C. jejuni, however 
when the concentration falls to those found in the proxi-
mal colon [46], the T6SS system is expressed and this 
contributes to colonic inflammation in humans [14]. In 
this study the resistance of the isolates to bile salts were 
compared with the human isolate C. jejuni 12502, reveal-
ing that most isolates had no resistance to levels of bile 
salts previously described as minimally inhibitory con-
centrations [45].
Conclusion
Taken together, all these results show that the hcp gene 
and the complete T6SS are prevalent in C. coli as well 
as in C. jejuni isolates obtained from retail chicken at a 
very high rate. Overall the results suggest that C. jejuni 
and C. coli chicken isolates containing the complete T6SS 
ORFs potentially have greater virulence in vitro, than do 
reference strains, but the consequences of these factors, 
in vivo, has yet to be determined.
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